2008
DOI: 10.1007/s10787-007-1614-0
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice

Abstract: We investigated the effects of the polyphenolic compound curcumin and its metabolite tetrahydrocurcumin (ThC), in the model of Parkinson's disease induced in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this model depletion of dopamine(DA) and DOPAC (3,4-dihydroxy phenyl acetic acid)) occurs with increased monoamine oxidase (MAO-B) activity. We used HPLC with electrochemical detection to measure DA and DOPAC respectively while MAO-B was assayed by spectroflourimetry using the conversion of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
73
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 155 publications
(85 citation statements)
references
References 12 publications
6
73
0
1
Order By: Relevance
“…These data suggest that the dienone bridge that is present in curcumin, but not in THC, is necessary to reduce plaque deposition and protein oxidation in an Alzheimer model. Rajeswari and Sabesan [57] compared the effects of curcumin with those of THC in a model of Parkinson disease induced in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this model, depletion of dopamine (DA) and DOPAC (3,4-dihydroxy phenyl acetic acid) occurred with increased monoamine oxidase (MAO-B) activity.…”
Section: Neurologic Effectsmentioning
confidence: 99%
“…These data suggest that the dienone bridge that is present in curcumin, but not in THC, is necessary to reduce plaque deposition and protein oxidation in an Alzheimer model. Rajeswari and Sabesan [57] compared the effects of curcumin with those of THC in a model of Parkinson disease induced in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this model, depletion of dopamine (DA) and DOPAC (3,4-dihydroxy phenyl acetic acid) occurred with increased monoamine oxidase (MAO-B) activity.…”
Section: Neurologic Effectsmentioning
confidence: 99%
“…As M. communis leaf extract is rich in polyphenolic compounds such as tannins, it is able to inhibit mono amino oxidase enzyme (MAO) and in this way it can interfere in the action of neurotransmitters in the brain. The use of MAO inhibitors in rats can change TSH release patterns, resulting in decreased transport of iodine [6,7]. Thyroid MAO enzyme is involved in the biosynthesis of thyroid hormones due to its ability to produce hydrogen peroxide [8].…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that tetrahydrocurcumin possesses hepatoprotective effects against chloroquine-induced hepatotoxicity in rats by decreasing the levels of enzymatic and non-enzymatic antioxidant activities (Murugavel and Pari 2004;Pari and Amali 2005). In neurogenerative disorders, tetrahydrocurcumin increases the level of dopamine through the inhibition of monoamine oxidase activity in an animal model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Rajeswari and Sabesan 2008). Moreover, tetrahydrocurcumin reduces amyloid-β-induced oxidative stress and neurotoxicity by regenerating the mitochondrial membrane potential and inhibiting ROS generation and casspase-3 activity in rat hippocampal and human neuronal cells (Mishra et al 2011).…”
Section: Tetrahydrocurcuminmentioning
confidence: 99%